Change of telomerase activity in rectal cancer with chemoradiation therapy.
Telomerase, an enzyme associated with cellular immortality, is expressed by most malignant cells and is inactive in most normal somatic cells, with the exception of proliferative stem cells, germ cells and activated lymphocytes. Measuring telomerase activity clinically may provide useful diagnostic...
Main Authors: | Kim, H. R., Kim, Y. J., Kim, H. J., Kim, S. K., Lee, J. H. |
---|---|
Format: | Online |
Language: | English |
Published: |
Korean Academy of Medical Sciences
2000
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054616/ |
Similar Items
-
Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer
by: Jwa, E, et al.
Published: (2014) -
Multimodal Assessments Are Needed for Restaging after Neoadjunvant Chemoradiation Therapy in Rectal Cancer Patients
by: Kye, Bong-Hyeon, et al.
Published: (2016) -
Short–term effects of neoadjuvant chemoradiation therapy on anorectal function in rectal cancer patients: a pilot study
by: Kye, Bong-Hyeon, et al.
Published: (2013) -
New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer
by: Kim, Nam Kyu, et al.
Published: (2015) -
Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
by: Ferrari, Linda, et al.
Published: (2015)